TARS logo

Tarsus Pharmaceuticals (TARS) Accounts receivable

Annual accounts receivable:

$46.76M+$30.14M(+181.33%)
December 31, 2024

Summary

  • As of today (May 23, 2025), TARS annual accounts receivable is $46.76 million, with the most recent change of +$30.14 million (+181.33%) on December 31, 2024.
  • TARS annual accounts receivable is now at all-time high.

Performance

TARS Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Quarterly accounts receivable:

$62.43M+$15.67M(+33.50%)
March 31, 2025

Summary

  • As of today (May 23, 2025), TARS quarterly accounts receivable is $62.43 million, with the most recent change of +$15.67 million (+33.50%) on March 31, 2025.
  • Over the past year, TARS quarterly accounts receivable has increased by +$32.54 million (+108.89%).
  • TARS quarterly accounts receivable is now at all-time high.

Performance

TARS Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TARS Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+181.3%+108.9%
3 y3 years-+10000.0%
5 y5 years--

TARS Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%at high>+9999.0%
5 y5-yearat high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

TARS Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$62.43M(+33.5%)
Dec 2024
$46.76M(+181.3%)
$46.76M(+60.4%)
Sep 2024
-
$29.16M(-1.3%)
Jun 2024
-
$29.53M(-1.2%)
Mar 2024
-
$29.89M(+79.8%)
Dec 2023
$16.62M
$16.62M(+210.0%)
Sep 2023
-
$5.36M(+114.5%)
DateAnnualQuarterly
Mar 2023
-
$2.50M(>+9900.0%)
Dec 2022
$0.00
$0.00(-100.0%)
Sep 2022
-
$17.00K(0.0%)
Jun 2022
-
$17.00K(0.0%)
Mar 2022
-
$17.00K(-99.9%)
Jun 2021
-
$20.00M(-20.0%)
Mar 2021
-
$25.00M

FAQ

  • What is Tarsus Pharmaceuticals annual accounts receivable?
  • What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?

What is Tarsus Pharmaceuticals annual accounts receivable?

The current annual accounts receivable of TARS is $46.76M

What is the all time high annual accounts receivable for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual accounts receivable is $46.76M

What is Tarsus Pharmaceuticals annual accounts receivable year-on-year change?

Over the past year, TARS annual accounts receivable has changed by +$30.14M (+181.33%)

What is Tarsus Pharmaceuticals quarterly accounts receivable?

The current quarterly accounts receivable of TARS is $62.43M

What is the all time high quarterly accounts receivable for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly accounts receivable is $62.43M

What is Tarsus Pharmaceuticals quarterly accounts receivable year-on-year change?

Over the past year, TARS quarterly accounts receivable has changed by +$32.54M (+108.89%)
On this page